4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
3.190
-0.440 (-12.13%)
Mar 31, 2025, 1:13 PM EDT - Market open
FDMT's stock price has decreased by -89.58% in the past year and price targets may not have had time to catch up.
4D Molecular Therapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Buy
Price Target
$35.00
Upside
+997.28%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $42 → $40 | Strong Buy | Maintains | $42 → $40 | +1,154.04% | Mar 10, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $30 → $28 | Strong Buy | Maintains | $30 → $28 | +777.83% | Mar 4, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $39 → $35 | Buy | Maintains | $39 → $35 | +997.28% | Mar 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +1,028.63% | Mar 3, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $39 → $30 | Strong Buy | Maintains | $39 → $30 | +840.53% | Feb 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +1,028.63% | Feb 10, 2025 |
| Morgan Stanley | Morgan Stanley | Sell Maintains $8 → $6 | Sell | Maintains | $8 → $6 | +88.11% | Jan 13, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $31 → $27 | Buy | Maintains | $31 → $27 | +746.47% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +1,028.63% | Jan 13, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $79 → $46 | Strong Buy | Maintains | $79 → $46 | +1,342.14% | Dec 18, 2024 |
| Morgan Stanley | Morgan Stanley | Sell Initiates $8 | Sell | Initiates | $8 | +150.81% | Nov 21, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $39 | Strong Buy | Maintains | $39 | +1,122.69% | Nov 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +1,028.63% | Nov 14, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $40 → $39 | Buy | Maintains | $40 → $39 | +1,122.69% | Nov 14, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Sep 23, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $38 → $39 | Strong Buy | Maintains | $38 → $39 | +1,122.69% | Sep 19, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.